Different regimens of perioperative chemotherapy for esophagogastric and gastric adenocarcinoma: does a triplet therapy with taxane generate a survival benefit?

Transl Gastroenterol Hepatol. 2017 Mar 30:2:25. doi: 10.21037/tgh.2017.03.07. eCollection 2017.

Authors

Nicole Samm¹, Alexander Novotny¹, Helmut Friess¹, Daniel Reim¹

Affiliation

¹ Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

No abstract available

Publication types

Editorial
Comment